Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jupiter Wellness, Inc. - Common Stock (NQ: JUPW )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 14, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jupiter Wellness, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
16 Stocks Moving in Friday's Pre-Market Session
Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after... 
Via Benzinga
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets... 
From Jupiter Wellness, Inc.
Via AccessWire
Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology
Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the Studies JUPITER, FL / ACCESSWIRE / April 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market
- Jupiter licenses exclusive worldwide rights for unique formulas addressing jellyfish and man o' war stings, sea lice, and swimmer's itch with 4 patents-pending - Estimated 150 million people are... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
64 Biggest Movers From Friday
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed... 
Via Benzinga
34 Stocks Moving in Friday's Pre-Market Session
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22... 
Via Benzinga
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Gainers Eastside Distilling (NASDAQ:EAST) shares rose 9.1% to $1.05 during Monday's after-market session. The company's market cap stands at $16.6 million. 
Via Benzinga
Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis
Data expected Q1 2022 on efficacy of JW-200 to clear AK lesions, a common form of pre-cancerous growth that left untreated can lead to cancer in up to 15% of patients JUPITER, FL / ACCESSWIRE /... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga
JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that its merger partner Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui was... 
From Jupiter Wellness, Inc.
Via AccessWire
Benzinga Announces This Week's All Access Guests
Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 11 at 9:15 am ET. The Lineup 9:15 am... 
Via Benzinga
Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network
Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc.... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation
- Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution - Next Frontier Pharmaceuticals has completed a pre-IND... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
The Week In Cannabis: Amazon Supports Legalization, NY Expands Its Medical Program, Stocks Underperform And More
Below is a recap of the main news related to the cannabis industry and markets for the week of January 24, 2022. Contents 
Via Benzinga
Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program
Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders
Jupiter Wellness, Inc. (NASDAQ:JUPW) revealed 
Via Benzinga
Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders
SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier... 
From Jupiter Wellness, Inc.
Via AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market
Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics - Benuvia has begun focusing on Psilocybin, DMT, and MDMA. - Benuvia's 83,000 square foot... 
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Jupiter Wellness Issues Letter to Stockholders
JUPITER, FL / ACCESSWIRE / January 10, 2022 / Jupiter Wellness Issues Letter to Stockholders: Dear Fellow Stockholders, Jupiter Wellness, Inc. ("Jupiter", or the "Company"), has, we believe,... 
From Jupiter Wellness, Inc.
Via AccessWire
52 Weeks High And Low Article
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x... 
Via Benzinga
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
Photo by Michael Longmire on... 
Via Benzinga
Jupiter (JUPW) Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Jupiter Wellness, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – JUPW
From Halper Sadeh LLP
Via Business Wire
The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Link Between Cannabis Consumption and Sleep — Cannabis Daily December 10, 2021
The Best Daily Overview Of The Cannabis Space Governor of Kentucky looking to legalize medical marijuana in the coming legislativ... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Jupiter Wellness Just Reported A Big Move In Pharma
Image provided by Jupiter Wellness of their new lab. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content... 
Via Benzinga
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals
Via Get News
Exposures Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! It's the last day of the trading week and we're starting it with the biggest pre-market stock movers for Friday! 
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Jupiter Wellness & Next Frontier Pharmaceuticals Merge, Will Expand Cannabinoid & Psychedelics Drug Development
Jupiter Wellness, Inc. (NASDAQ:JUPW) announced Thursday th... 
Via Benzinga
Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals
- Owner of SYNDROS®(dronabinol), the only US-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat: Chemotherapy Induced Nausea and Vomiting (CINV) associated... 
From Jupiter Wellness, Inc.
Via AccessWire
Topics Cannabis Intellectual Property Regulatory Compliance
Exposures Cannabis Intellectual Property Legal
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals. Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals: (NASDAQ: JUPW) Jupiter Wellness
Via Viz Release
Topics Intellectual Property
Exposures Intellectual Property Product Safety
TLRY is Making waves along with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: JUPW) Jupiter Wellness
Via Viz Release
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.